On this page
⚠ Educational content only Not medical or genetic advice. Speak with a healthcare provider or genetic counsellor before acting on anything here.

FKRP

fukutin related protein

The FKRP gene provides instructions for producing fukutin-related protein, which is crucial for the normal glycosylation of alpha-dystroglycan, a protein vital for muscle and brain function. The FKRP gene is responsible for encoding fukutin-related protein (FKRP), an enzyme that plays a key role in the glycosylation pathway.

Chromosome 19q13.32 Autosomal recessive HGNC:17997 Tier C
FKRP 19q13.32 p arm q arm 19

FKRP is located on the long (q) arm of chromosome 19, at band 19q13.32. Arm ratio per GRCh38 - banding schematic.

Explore chromosome 19 in the library →

Available at Jeen Health

Clinical tests that include this

Overview

The FKRP gene, or fukutin related protein, is involved in a vital cellular process known as glycosylation. This gene's product, the FKRP protein, is found in various body tissues, with high concentrations in the brain, heart, and skeletal muscles. Its proper function is integral to normal muscle and brain development.

What the gene does

The FKRP protein functions primarily within the Golgi apparatus, a cellular organelle responsible for modifying newly synthesised proteins. Its main role is in glycosylation, specifically by adding a molecule called ribitol 5-phosphate to the sugar chain of alpha (α)-dystroglycan. This glycosylation is fundamental for α-dystroglycan to perform its critical functions. In skeletal muscles, properly glycosylated α-dystroglycan helps to stabilise and protect muscle fibres. In the brain, it is involved in directing the migration of nerve cells during early developmental stages, ensuring correct brain structure and function. FKRP therefore plays a crucial part in the structural integrity of muscle tissue and neurological development.

Video: Genetics 101

Chromosome location

The FKRP gene is located on chromosome 19, specifically at position 19q13.32. This genomic location positions FKRP within the long arm of chromosome 19. The gene encodes a protein composed of 495 amino acids.

Protein structure

The FKRP protein has a total length of 495 amino acids. One notable feature within its structure is a Zinc finger loop, which spans amino acids 289-318. The overall domain architecture has not been experimentally characterised in detail for this protein.

Domain map · 495 amino acids
Zinc finger loop (289-318)Zinc finger loop289-3181~248495
Region - functional region
🧬 Explore 3D structure on AlphaFold
UniProt:Q9H9S5Length:495 aaStructure:AlphaFold

Key variants

Variants in the FKRP gene can lead to a spectrum of conditions, ranging in severity. These genetic changes can impair the normal function of the fukutin-related protein, affecting the essential glycosylation process it facilitates. The impact of these variants can vary widely depending on their specific nature and location within the gene.

The table below shows the top 10 pathogenic or likely-pathogenic variants currently classified in ClinVar for FKRP.
View all on ClinVar →

Sample of pathogenic variants

10 pathogenic / likely-pathogenic variants from ClinVar, ranked by review status (expert-panel-reviewed first). This is a sample; recurrent founder variants in a specific population may not appear here - see the full ClinVar listing via the link above.

Variant (HGVS) Protein change Classification Evidence Associated condition
c.1000G>T
single nucleotide variant
p.Glu334Ter Pathogenic/Likely pathogenic ★★☆☆ Walker-Warburg congenital muscular dystrophy
c.1020C>G
single nucleotide variant
p.Tyr340Ter Pathogenic/Likely pathogenic ★★☆☆ Autosomal recessive limb-girdle muscular dystrophy type 2I
c.1077G>A
single nucleotide variant
p.Trp359Ter Pathogenic/Likely pathogenic ★★☆☆ Walker-Warburg congenital muscular dystrophy
c.1208dup
Duplication
p.Arg404fs Pathogenic/Likely pathogenic ★★☆☆ Walker-Warburg congenital muscular dystrophy
c.1216C>T
single nucleotide variant
p.Gln406Ter Pathogenic/Likely pathogenic ★★☆☆ Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A5
c.159_160delinsTT
Indel
p.Arg54Trp Pathogenic ★★☆☆ Autosomal recessive limb-girdle muscular dystrophy
c.217C>T
single nucleotide variant
p.Gln73Ter Pathogenic ★★☆☆ Walker-Warburg congenital muscular dystrophy
c.265C>G
single nucleotide variant
p.Pro89Ala Pathogenic/Likely pathogenic ★★☆☆ Walker-Warburg congenital muscular dystrophy
c.651_652dup
Duplication
p.Val218fs Pathogenic/Likely pathogenic ★★☆☆ Cardiovascular phenotype
c.795_811del
Deletion
p.Ala267fs Pathogenic/Likely pathogenic ★★☆☆ Walker-Warburg congenital muscular dystrophy

Evidence stars indicate ClinVar review status. Individual variant interpretation should always be performed by a qualified clinical laboratory - many variants remain classified as Variants of Uncertain Significance (VUS) pending more research.

Associated conditions

Pathogenic variants in the FKRP gene are associated with a group of inherited muscle and brain disorders. The most severe condition linked to FKRP is Walker-Warburg syndrome, which manifests with profound muscle weakness and abnormalities of the brain and eyes. Other conditions include various forms of congenital muscular dystrophy and limb-girdle muscular dystrophy, all of which involve muscle weakness and, in some cases, intellectual disability or eye problems.

  • Walker-Warburg syndrome
    Neurogenetics
    AR
    Dedicated page coming soon

Inheritance pattern

Conditions caused by pathogenic FKRP variants typically follow autosomal recessive inheritance.

♀ Carrier parent 1 altered copy ♂ Carrier parent 1 altered copy Affected Carrier Carrier Unaffected Affected Carrier Unaffected Circles = females · Squares = males

When both parents are carriers, each child has a 25% chance of being affected, 50% of being a carrier, and 25% of being unaffected.

Carrier frequency by population How common is heterozygous FKRP carrier status across ancestry groups?

UK clinical status

The FKRP gene is included in several expert-curated panels within the NHS Genomic Medicine Service's PanelApp. It is covered for conditions such as Acute rhabdomyolysis (R419), Arthrogryposis (R83), Congenital muscular dystrophy (R79), Foetal anomalies (R21), Hydrocephalus (R86), Limb girdle muscular dystrophies, myofibrillar myopathies and distal myopathies (R82), and Paediatric or syndromic cardiomyopathy (R135). FKRP is also part of panels for Congenital disorders of glycosylation, Intellectual disability, and Malformations of cortical development.

Frequently asked questions

What is the primary function of the FKRP gene?

The FKRP gene provides instructions for the fukutin-related protein, which is critical for a process called glycosylation. This process modifies alpha-dystroglycan, a protein essential for muscle stability and brain development.

Which conditions are associated with variants in the FKRP gene?

Variants in the FKRP gene are primarily associated with a range of muscular dystrophies, including Walker-Warburg syndrome, a severe form of congenital muscular dystrophy, and limb-girdle muscular dystrophy.

Where is the FKRP gene located?

The FKRP gene is located on chromosome 19, specifically at the 19q13.32 position. This region contains the genetic instructions for the fukutin-related protein.

References

  1. Kanagawa M, Kobayashi K, Tajiri M. Identification of a Post-translational Modification with Ribitol-Phosphate and Its Defect in Muscular Dystrophy. Cell reports. 2016. PMID: 26923585
  2. Gerin I, Ury B, Breloy I. ISPD produces CDP-ribitol used by FKTN and FKRP to transfer ribitol phosphate onto α-dystroglycan. Nature communications. 2016. PMID: 27194101
  3. Trovato R, Astrea G, Bartalena L. Elevated serum creatine kinase and small cerebellum prompt diagnosis of congenital muscular dystrophy due to FKRP mutations. Journal of child neurology. 2014. PMID: 23420653
  4. Willer T, Inamori K, Venzke D. The glucuronyltransferase B4GAT1 is required for initiation of LARGE-mediated α-dystroglycan functional glycosylation. eLife. 2014. PMID: 25279699
  5. Kava M, Chitayat D, Blaser S. Eye and brain abnormalities in congenital muscular dystrophies caused by fukutin-related protein gene (FKRP) mutations. Pediatric neurology. 2013. PMID: 24139536
  6. Esapa CT, McIlhinney RA, Blake DJ. Fukutin-related protein mutations that cause congenital muscular dystrophy result in ER-retention of the mutant protein in cultured cells. Human molecular genetics. 2005. PMID: 15574464
  7. Boito CA, Melacini P, Vianello A. Clinical and molecular characterization of patients with limb-girdle muscular dystrophy type 2I. Archives of neurology. 2005. PMID: 16344347
  8. Beltran-Valero de Bernabé D, Voit T, Longman C. Mutations in the FKRP gene can cause muscle-eye-brain disease and Walker-Warburg syndrome. Journal of medical genetics. 2004. PMID: 15121789
  9. Esapa CT, Benson MA, Schröder JE. Functional requirements for fukutin-related protein in the Golgi apparatus. Human molecular genetics. 2002. PMID: 12471058
Educational content. This page is not medical or genetic advice, is not individually reviewed by a clinician for each reader, and should not replace a consultation with a qualified healthcare professional or genetic counsellor. If you are considering genetic testing or acting on a test result, book a consultation.
Data sources Last updated 18 October 2026. Content compiled from HGNC · MedlinePlus Genetics · ClinGen · Genomics England PanelApp · NHS National Genomic Test Directory · ClinVar · UniProt · AlphaFold .